Topical corticosteroid withdrawal syndrome: the patient community call for high-quality research, clear definitions and diagnostic criteria
Br J Dermatol
.
2023 Feb 10;188(2):288-289.
doi: 10.1093/bjd/ljac067.
Authors
Laura Howells
1
,
Holly Broome
2
,
Alice Burleigh
2
,
Harriet Hammond
2
,
Farhan Ismail
2
,
Andrew Proctor
3
,
Amanda Roberts
4
,
Kim S Thomas
1
,
Paul Leighton
1
Affiliations
1
Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
2
Scratch That, UK.
3
National Eczema Society, UK.
4
Patient and public contributor, Nottingham, UK.
PMID:
36763872
DOI:
10.1093/bjd/ljac067
No abstract available
MeSH terms
Administration, Topical
Adrenal Cortex Hormones / adverse effects
Humans
Substance Withdrawal Syndrome* / diagnosis
Substance Withdrawal Syndrome* / etiology
Substances
Adrenal Cortex Hormones
Grants and funding
NH/NIH HHS/United States